Literature DB >> 27834588

Generation of GGTA1 Mutant Pigs by Direct Pronuclear Microinjection of CRISPR/Cas9 Plasmid Vectors.

Chin-Kai Chuang1, Chien-Hong Chen1, Chung-Ling Huang1, Yu-Hsiu Su1, Shu-Hui Peng1, Tai-Yun Lin1, Hao-Chih Tai2, Tien-Shuh Yang3, Ching-Fu Tu1.   

Abstract

This study was conducted to confirm that 1-site and 4-site ppU6-GGTA1-gRNA CRISPR vectors together with the pCX-Flag2-NLS1-Cas9-NLS2 plasmid can both generate KO pigs by direct pronuclear microinjection. In total, 41 and 53 fertilized eggs were microinjected on 1-site and 4-site strategies, respectively. The 1-site construction generated a litter of 8 piglets, and 2 were mono-allelic mutant (mMt). The injection of 4-site constructions resulted in one biallelic mutant (bMt) and one mMt piglet in a litter of 7. Those 3 mMt pigs had a 4 bp deletion, 5 bp insertion, or 7 bp insertion at site I, and the bMt pig had 5 types of mutations at cleavage sites I and III. The expression of alpha-Gal on the bMt peripheral blood mononuclear cells (PBMCs) was reduced, and survival rate of bMt PBMCs was maintained as indicated by results of cultivation with sera of humans or Formosan Macaques. We concluded that mutant pigs could be generated by direct pronuclear microinjection of ppU6-GGTA1-gRNA CRISPR vectors with the pCX-Flag2-NLS1-Cas9-NLS2 plasmid and that the 4-site strategy has a better mutant efficiency. Porcine U6 promoter was firstly used to express KO vectors and effectively generate mutant pigs, worthily to adopt for future KO studies.

Entities:  

Keywords:  CRISPR/Cas9 KO Plasmid; GGTA1 mutant pigs; RNA polymerase III promoter; pronuclear microinjection

Mesh:

Substances:

Year:  2016        PMID: 27834588     DOI: 10.1080/10495398.2016.1246453

Source DB:  PubMed          Journal:  Anim Biotechnol        ISSN: 1049-5398            Impact factor:   2.282


  21 in total

1.  CRISPR therapy towards an HIV cure.

Authors:  Elena Herrera-Carrillo; Zongliang Gao; Ben Berkhout
Journal:  Brief Funct Genomics       Date:  2020-05-20       Impact factor: 4.241

2.  Porcine germline genome engineering.

Authors:  Luhan Yang; George Church; Hong-Ye Zhao; Lusheng Huang; Yangbin Gao; Hong-Jiang Wei; Geoffrey Yang
Journal:  Proc Natl Acad Sci U S A       Date:  2021-04-30       Impact factor: 11.205

3.  Generation of Mutant Pigs by Direct Pronuclear Microinjection of CRISPR/Cas9 Plasmid Vectors.

Authors:  Chin-Kai Chuang; Ching-Fu Tu; Chien-Hong Chen
Journal:  Bio Protoc       Date:  2017-06-05

Review 4.  Application of CRISPR/Cas9 System in Establishing Large Animal Models.

Authors:  Yingqi Lin; Jun Li; Caijuan Li; Zhuchi Tu; Shihua Li; Xiao-Jiang Li; Sen Yan
Journal:  Front Cell Dev Biol       Date:  2022-05-17

Review 5.  CRISPR-Cas9-Based Technology and Its Relevance to Gene Editing in Parkinson's Disease.

Authors:  Mujeeb Ur Rahman; Muhammad Bilal; Junaid Ali Shah; Ajeet Kaushik; Pierre-Louis Teissedre; Małgorzata Kujawska
Journal:  Pharmaceutics       Date:  2022-06-13       Impact factor: 6.525

6.  Evaluation of the CRISPR/Cas9 Genetic Constructs in Efficient Disruption of Porcine Genes for Xenotransplantation Purposes Along with an Assessment of the Off-Target Mutation Formation.

Authors:  Natalia Ryczek; Magdalena Hryhorowicz; Daniel Lipiński; Joanna Zeyland; Ryszard Słomski
Journal:  Genes (Basel)       Date:  2020-06-26       Impact factor: 4.096

Review 7.  Delivering CRISPR: a review of the challenges and approaches.

Authors:  Christopher A Lino; Jason C Harper; James P Carney; Jerilyn A Timlin
Journal:  Drug Deliv       Date:  2018-11       Impact factor: 6.419

8.  Crosstalk between Peroxisomal Activities and Nrf2 Signaling in Porcine Embryos.

Authors:  Eui-Hyun Kim; Muhammad-Rosyid Ridlo; Byeong-Chun Lee; Geon A Kim
Journal:  Antioxidants (Basel)       Date:  2021-05-13

9.  Directions and applications of CRISPR technology in livestock research.

Authors:  IsmaeI Lamas-Toranzo; Priscila Ramos-Ibeas; Eva Pericuesta; Pablo Bermejo-Álvarez
Journal:  Anim Reprod       Date:  2018-08-17       Impact factor: 1.807

Review 10.  Current status of the application of gene editing in pigs.

Authors:  Fuminori Tanihara; Maki Hirata; Takeshige Otoi
Journal:  J Reprod Dev       Date:  2021-04-10       Impact factor: 2.214

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.